Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
The zoster vaccine, known primarily by its brand name [Shingrix] (Recombinant Zoster Vaccine, or RZV), is an inactivated vaccine used to prevent shingles (herpes zoster) and its most common complication, postherpetic neuralgia (PHN). Because it is a non-live recombinant vaccine, it contains only a small component of the virus alongside an immune-boosting adjuvant, meaning it cannot cause shingles or chickenpox
The zoster vaccine, known primarily by its brand name [Shingrix] (Recombinant Zoster Vaccine, or RZV), is an inactivated vaccine used to prevent shingles (herpes zoster) and its most common complication, postherpetic neuralgia (PHN). Because it is a non-live recombinant vaccine, it contains only a small component of the virus alongside an immune-boosting adjuvant, meaning it cannot cause shingles or chickenpox